Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  EGFRBi-armed autologous activated T cells
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
EGFRBi-Armed Autologous T Cells in Treating Patients with Recurrent or Refractory Glioblastoma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2014-112, NCI-2015-00232, NCT02521090
Start Over